Howard Hughes Medical Institute’s Akamai AKAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-31
Closed -$2.71K 49
2025
Q4
$2.71K Hold
31
﹤0.01% 440
2025
Q3
$2.35K Sell
31
-1
-3% -$77 ﹤0.01% 455
2025
Q2
$2.55K Buy
+32
New +$2.49K ﹤0.01% 437

Other funds holding AKAM

Howard Hughes Medical Institute's AKAM Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Akamai (AKAM) in Q1 2026, closing a stake of 31 shares — an estimated $2.71K sold.

Howard Hughes Medical Institute first reported a position in AKAM in Q2 2025 and held it in 3 quarters. The position peaked at $2.71K in Q4 2025. 771 funds tracked by Wall St. Rank hold AKAM as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Akamai position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 31 Akamai shares in Q1 2026, an estimated $2.71K.
  • Howard Hughes Medical Institute first reported a position in Akamai in Q2 2025 and held it in 3 quarters.
  • Howard Hughes Medical Institute's Akamai position peaked at $2.71K in Q4 2025.
  • 771 funds tracked by Wall St. Rank held Akamai as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.